Acute pancreatitis with gliptins: Is it a clinical reality?
There are reports of acute pancreatitis with the use of dipeptidyl peptidase-4 inhibitors (gliptins). This class of drugs is widely being prescribed for type 2 diabetes mellitus (DM) in our country. We evaluated the incidence of acute pancreatitis with the use of gliptins during the period January 2...
Main Authors: | Muthukrishnan Jayaraman, Sandeep Kumar, Atul Kumar Sood |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer Medknow Publications
2013-01-01
|
Series: | Indian Journal of Endocrinology and Metabolism |
Subjects: | |
Online Access: | http://www.ijem.in/article.asp?issn=2230-8210;year=2013;volume=17;issue=7;spage=323;epage=325;aulast=Jayaraman |
Similar Items
-
Choosing a Gliptin
by: Vishal Gupta, et al.
Published: (2011-01-01) -
The regulatory role of DPP4 in atherosclerotic disease
by: Lihua Duan, et al.
Published: (2017-06-01) -
Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients
by: Dana Shalmon, et al.
Published: (2024-04-01) -
The association of bullous pemphigoid with dipeptidyl-peptidase 4 inhibitors: a ten-year prospective observational study
by: Vaia Lambadiari, et al.
Published: (2021-02-01) -
Gliptin Accountability in Mucous Membrane Pemphigoid Induction in 24 Out of 313 Patients
by: Olivier Gaudin, et al.
Published: (2018-05-01)